Phase 2 Trial of Bi-weekly Cetuximab for Recurrent or Metastatic Colorectal Cancer (BIC-K Trial)

Authors :: Toru Mukohara
Naomi Kiyota
Naoko Chayahara
Hironaga Satake
Hironobu Minami
Masahito Kotaka
Masanori Toyoda
Yoshimi Fujishima
Sahchiko Kimura
Akihito Tsuji
Source :: Annals of Oncology. 27:vii77-vii78
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Cetuximab
Colorectal cancer
business.industry
Internal medicine
medicine
Hematology
medicine.disease
business
medicine.drug

Full Text Access

Tools